
1. mol med rep. 2017 nov;16(5):6389-6395. doi: 10.3892/mmr.2017.7362. epub 2017 aug 
24.

effects artesunate prevent nephritis via toll‑like receptor 4/nuclear
factor‑κb signaling pathway rats.

wan rj(1), li yh(1).

author information: 
(1)department urology, tianjin nankai hospital, tianjin, nankai 300100, p.r.
china.

the active ingredient artemisia carvifolia, artemisinin, may alleviate
inflammation toxicity. artemisinin derivatives first‑line
anti‑malarial drugs currently, rapid effects fever caused by
malaria parasites fewer side effects. present study investigated the
effects artesunate mouse nephritis model. mice injected
intraperitoneally 500 µl pristine induce nephritis, treated with
28.8 mg/kg artesunate. subsequently, proteinuria, renal function, tumor
necrosis factor (tnf)‑α interleukin (il)‑6 levels assessed evaluate
the effects artesunate nephritis. western blot analysis used measure
the protein expression levels α‑smooth muscle actin (sma), tlr4, myeloid
differentiation primary response gene 88 (myd88), nf‑κb p65 transforming
growth factor (tgf)‑β1 investigate underlying mechanisms artesunate 
nephritis. results demonstrated artesunate reduced proteinuria and
preserved renal function nephritis mice. artesunate attenuated tnf‑α il‑6 
levels, suppressed α‑sma, tlr4, myd88, nf‑κb p65 tgf‑β1 protein expression,
and decreased caspase‑3 activity nephritis mice. results indicated 
the effects artesunate may prevent nephritis inhibit inflammation via 
tlr4/nf‑κb signaling pathway mice. therefore, artesunate may potential
therapeutic agent prevent nephritis.

doi: 10.3892/mmr.2017.7362 
pmid: 28849172  [indexed medline]

